Pfizer and BioNTech say their COVID-19 vaccine is safe and highly effective — including against South Africa variant

There was welcome news on the COVID-19 vaccine front Thursday, as Pfizer Inc. and German partner BioNTech SE said a follow-up study of their vaccine found it remained safe and highly effective six months after a second dose.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.